| 英文别名 |
Levocabastine Hydrochloride;(3S,4R)-Cabastine;(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid,hydrochloride;(3S,4R)-Cabastine Hydrochloride;LEVOCABASTINE HCL;levocabastin;Levocabastine;levocobastine;Levophta;Livostin;R 50,547;UNII-124XMA6YEI;Levostin;[3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid;R50547;Levocabastine hydrochloride;Q27251370;D01717;CCG-221039;Levocabastine hydrochloride [USAN:USP];LEVOCABASTINE HYDROCHLORIDE [USP-RS];MLS002154116;NCGC00016939-01;CHEBI:31777;(-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid monohydrochloride;HMS1571O19;CS-0031223;DTXCID7025508;SCHEMBL99970;4-Piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (3S,4R)-;SMR001233423;LEVOCABASTINE HYDROCHLORIDE [USP MONOGRAPH];LEVOCABASTINE HYDROCHLORIDE [USP IMPURITY];(3S,4R)-1-((1s,4R)-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride;NCGC00179240-04;124XMA6YEI;4-PIPERIDINECARBOXYLIC ACID, 1-(4-CYANO-4-(4-FLUOROPHENYL)CYCLOHEXYL)-3-METHYL-4-PHENYL-, MONOHYDROCHLORIDE, (-)-(1(CIS),3.ALPHA.,4.BETA.)-;Levocabastine for system suitability 2, European Pharmacopoeia (EP) Reference Standard;R-50547;4-Piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (-)-(1(cis),3alpha,4beta)-;AKOS040744670;AT25912;LEVOCABASTINE HYDROCHLORIDE [MART.];Levocabastine hydrochloride, >=99% (HPLC), solid;SCHEMBL99969;LEVOCABASTINE HYDROCHLORIDE [EP MONOGRAPH];CAS-79547-78-7;Levocabastine hydrochloride, European Pharmacopoeia (EP) Reference Standard;LEVOCABASTINE HYDROCHLORIDE [VANDF];LEVOCABASTINE HYDROCHLORIDE [WHO-DD];Levocabastine hydrochloride, United States Pharmacopeia (USP) Reference Standard;HY-14277A;Levocabastine (hydrochloride);Tox21_110695;Levocabastine hydrochloride (JAN/USP);LEVOCABASTINE HYDROCHLORIDE [JAN];(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid;hydrochloride;79547-78-7;LEVOCABASTINE HYDROCHLORIDE [ORANGE BOOK];Levocabastine hydrochloride [USAN];LEVOCABASTINE HYDROCHLORIDE [EP IMPURITY];CHEMBL1237102;DTXSID9045508;Livostin (TN);Tox21_110695_1;4-Piperidinecarboxylic acid, 1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, [3S-[1(cis),3α,4β]]- (ZCI);4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, monohydrochloride, (3S,4R)- (9CI);1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid |
微信公众号
客服
